Matrix Metalloproteinase Inhibitors: A Structure−Activity Study
Levy, Daniel E, Lapierre, France, Liang, Weisheng, Ye, Wenqing, Lange, Christopher W, Li, Xiaoyuan, Grobelny, Damian, Casabonne, Marie, Tyrrell, David, Holme, Kevin, Nadzan, Alex, Galardy, Richard E
Published in Journal of medicinal chemistry (15.01.1998)
Published in Journal of medicinal chemistry (15.01.1998)
Get full text
Journal Article
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib
O'Hare, Thomas, Eide, Christopher A, Tyner, Jeffrey W, Corbin, Amie S, Wong, Matthew J, Buchanan, Sean, Holme, Kevin, Jessen, Katayoun A, Tang, Crystal, Lewis, Hal A, Romero, Richard D, Burley, Stephen K, Deininger, Michael W
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Get full text
Journal Article
Heparin in Inflammation: Potential Therapeutic Applications beyond Anticoagulation
Tyrrell, David J., Horne, Angela P., Holme, Kevin R., Preuss, Janet M.H., Page, Clive P.
Published in Advances in Pharmacology (1999)
Published in Advances in Pharmacology (1999)
Get full text
Book Chapter
Journal Article
Identification of Structural Features of Heparin Required for Inhibition of Herpes Simplex Virus Type 1 Binding
Herold, Betsy C., Gerber, Susan Ilene, Polonsky, Tamar, Belval, Brian J., Shaklee, Patrick N., Holme, Kevin
Published in Virology (New York, N.Y.) (01.02.1995)
Published in Virology (New York, N.Y.) (01.02.1995)
Get full text
Journal Article
Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor
Ishihara, M, Shaklee, P N, Yang, Z, Liang, W, Wei, Z, Stack, R J, Holme, K
Published in Glycobiology (Oxford) (01.08.1994)
Published in Glycobiology (Oxford) (01.08.1994)
Get more information
Journal Article
SGX393 inhibits the CML mutant Bcr-Abl[superscript T315I] and preempts in vitro resistance when combined with nilotinib or dasatinib
O'Hare, Thomas, Eide, Christopher A., Tyner, Jeffrey W., Corbin, Amie S., Wong, Matthew J., Buchanan, Sean, Holme, Kevin, Jessen, Katayoun A., Tang, Crystal, Lewis, Hal A., Romero, Richard D., Burley, Stephen K., Deininger, Michael W.
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Get full text
Journal Article
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Buchanan, Sean G, Hendle, Jorg, Lee, Patrick S, Smith, Christopher R, Bounaud, Pierre-Yves, Jessen, Katti A, Tang, Crystal M, Huser, Nanni H, Felce, Jeremy D, Froning, Karen J, Peterman, Marshall C, Aubol, Brandon E, Gessert, Steve F, Sauder, J Michael, Schwinn, Kenneth D, Russell, Marijane, Rooney, Isabelle A, Adams, Jason, Leon, Barbara C, Do, Tuan H, Blaney, Jeff M, Sprengeler, Paul A, Thompson, Devon A, Smyth, Lydia, Pelletier, Laura A, Atwell, Shane, Holme, Kevin, Wasserman, Stephen R, Emtage, Spencer, Burley, Stephen K, Reich, Siegfried H
Published in Molecular cancer therapeutics (01.12.2009)
Published in Molecular cancer therapeutics (01.12.2009)
Get full text
Journal Article
Modulation of nonspecific binding in ultrafiltration protein binding studies
LEE, Kyoung-Jin, MOWER, Rachel, HOLLENBECK, Tom, CASTELO, Jesus, JOHNSON, Nikole, GORDON, Perry, SINKO, Patrick J, HOLME, Kevin, LEE, Yong-Hee
Published in Pharmaceutical research (01.07.2003)
Published in Pharmaceutical research (01.07.2003)
Get full text
Journal Article
DP2 ANTAGONIST AND USES THEREOF
KING CHRISTOPHER DAVID, HOLME KEVIN ROSS, STEARNS BRIAN ANDREW, BRITTAIN JASON EDWARD
Year of Publication 11.05.2012
Get full text
Year of Publication 11.05.2012
Patent
Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer
Lee, Kyoung-Jin, Johnson, Nikole, Castelo, Jesus, Sinko, Patrick J., Grass, George, Holme, Kevin, Lee, Yong-Hee
Published in European journal of pharmaceutical sciences (01.06.2005)
Published in European journal of pharmaceutical sciences (01.06.2005)
Get full text
Journal Article
SGX393 inhibits the CML mutant Bcr-Abl T315I and preempts in vitro resistance when combined with nilotinib or dasatinib
O'Hare, Thomas, Eide, Christopher A., Tyner, Jeffrey W., Corbin, Amie S., Wong, Matthew J., Buchanan, Sean, Holme, Kevin, Jessen, Katayoun A., Tang, Crystal, Lewis, Hal A., Romero, Richard D., Burley, Stephen K., Deininger, Michael W.
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Get full text
Journal Article
SGX393 Inhibits the CML Mutant ${\rm Bcr}\text{-}{\rm Abl}^{{\rm T}315{\rm I}}$ and Preempts in vitro Resistance When Combined with Nilotinib or Dasatinib
O'Hare, Thomas, Eide, Christopher A., Tyner, Jeffrey W., Corbin, Amie S., Wong, Matthew J., Buchanan, Sean, Holme, Kevin, Jessen, Katayoun A., Tang, Crystal, Lewis, Hal A., Romero, Richard D., Burley, Stephen K., Deininger, Michael W.
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (08.04.2008)
Get full text
Journal Article